Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 2,484 $ 3,926
Restricted cash 63 63
Accounts receivable, net 5,189 4,631
Inventories, net 5,201 4,869
Deferred IPO costs 882 0
Prepaid expenses and other current assets 4,040 4,074
Total Current Assets 17,859 17,563
Property and equipment, net 149 252
Right-of-use assets, operating leases 94 345
Intangible assets, net 12,350 13,115
Goodwill 18,614 18,614
Other assets 114 1,364
Total Assets 49,180 51,253
Current Liabilities    
Term loans, net 704 7,826
Line of credit 222 0
PPP loans 0 190
Accrued liabilities 2,231 3,400
Accounts payable 4,758 3,137
Operating lease liability 56 173
Warrant liability 16,977 39,850
Total Current Liabilities 24,948 54,576
Non-current Liabilities    
Notes payable, net 0 18,910
Term loans, net 4,999 0
Lines of credit, net 4,935 5,023
PPP loans 0 662
Operating lease liability 38 184
Total Non-current Liabilities 9,972 24,779
Total Liabilities 34,920 79,355
Stockholders’ Equity (Deficit)    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 15,821,559 and 8,651,400 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 16 9
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 17,294 shares and 21,754 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 0 0
Additional paid-in capital 263,361 232,530
Accumulated deficit (249,117) (260,641)
Total Stockholders’ Equity (Deficit) 14,260 (28,102)
Total Liabilities and Stockholders’ Equity (Deficit) $ 49,180 $ 51,253